I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury

EJNMMI Research

Table 1 Patient characteristics

Patient no.	Age (year)	Sex	WAIS-R, WAIS-III, WISC-III			RBMT	Diagnosis at the time of the accident	Period after injury (month)		Main symptoms
			FIQ	VIQ	PIQ			FMZ	IMZ
1	28	M	98	105	90	21	No definite abnormalities	10	10	Irritability, poor concentration
2	51	M	100	99	100	20	Cerebral contusion	17	32	Difficulty of calculation
3	39	M	104	111	94	16	No definite abnormalities	4	10	Memory disorder
4	16	M	75	92	66	22	No definite abnormalities	2	13	Memory disorder
5	21	M	90	98	105	17	Cerebral contusion	2	6	Mental fatigue
6	28	F	85	84	90	23	Traumatic SAH, DAI, contusion	4	39	Memory disorder
7	29	F	106	101	101	22	ASDH	3	14	Mental fatigue

M male, F female, WAIS-R Wechsler Adult Intelligence Scale-Revised, WAIS-III Wechsler Adult Intelligence Scale-III, WISC-III Wechsler Intelligence Scale for Children-III, FIQ full intelligence quotient, VIQ verbal intelligence quotient, PIQ performance intelligence quotient, RBMT Rivermead Behavioral Memory Test, SAH subarachnoid hemorrhage, DAI diffuse axonal injury, ASDH acute subdural hematoma, FMZ C-11 flumazenil, IMZ I-123 iomazenil